Japanese drugmaker Eisai on Wednesday opened its $100 million, 65,000-square-foot manufacturing facility in Research Triangle Park.
The Tokyo company announced the project in 2006, lured partly by the promise of more than $1 million in state and local incentives. The new facility will produce intravenous drugs to treat diseases such as breast cancer, lung cancer and melanoma.
"The opening of this new facility marks a major milestone in our history," CEO Haruo Naito said in a prepared statement.




